Alison Watry

Four Ways Stem Cells Will Change the Face of Medicine

John Thomas, Eugene Brandon, Paula Cannon, Jill Helms, Alison Watry

Established in 2010 via Proposition 71, the California Institute for Regenerative Medicine has allocated over $2.2 billion to fund 65 entities, effectively bridging the "Valley of Death" between speculative research and commercial viability for incurable diseases. Recent breakthroughs include Dr. Eugene Brandon's encapsulated stem cell therapy for Type 1 diabetes, Dr. Paula Cannon's HIV-editing gene therapy trials, and Dr. Jill Helms's bone regeneration protocols using Wnt3a protein. Despite surging public support and promising clinical timelines for 2020 and beyond, the initiative faces a critical sustainability challenge as its $3 billion fund approaches depletion within three years while the NIH withdraws early-stage regenerative support.